GMO Pepabo, Inc. AI Stock Analysis
Want to see JP:3633 full AI Analyst Report?
GMO Pepabo, Inc. (3633) AI Stock Analysis
GMO Pepabo, Inc.
(TSE/TYO:3633)
The score is driven primarily by recovering financial performance (profitability rebound, healthier leverage, and strong recent cash generation) and favorable valuation (low P/E with a ~3% dividend yield). Offsetting these positives, technicals are very overbought (RSI ~90, Stoch ~94) despite a strong uptrend, increasing near-term pullback risk.
GMO Pepabo, Inc. (3633) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 12.06B
- Dividend Yield
- 2.88%
- Average Volume (3M)
- 34.13K
- Price to Earnings (P/E)
- 7.8
- Beta (1Y)
- 0.56
- Revenue Growth
- -3.72%
- EPS Growth
- 138.33%
- Country
- Japan
- Employees
- 307
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
GMO Pepabo, Inc. Business Overview & Revenue Model
Company Description
GMO Pepabo, Inc. delivers a variety of internet-based services tailored for individual consumers across Japan. The firm organizes its activities into four core divisions. Its Hosting segment supplies foundational services, including domain registrati...
GMO Pepabo, Inc. Financial Statement Overview
Summary
Financials show a solid recovery: net margin improved to ~8.0% in 2025 (from ~5.4% in 2024 and negative in 2023) with operating margin ~8.5% and consistently healthy gross margin (~53–58%). Balance sheet leverage improved meaningfully with debt-to-equity down to ~0.31 in 2025 (from ~0.82 in 2023). Cash flow is a recent strength (2025 OCF ~¥1.46B; FCF ~¥1.37B; FCF ~0.94x net income), but top-line growth has been flat/slightly down and cash flow has shown historical volatility (notably 2022).
Income Statement
68PositiveBalance Sheet
70PositiveCash Flow
73Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.83B | 10.96B | 10.92B | 10.90B | 10.53B | 11.88B |
| Gross Profit | 5.84B | 5.96B | 5.78B | 5.93B | 6.08B | 6.73B |
| EBITDA | 1.68B | 1.44B | 1.47B | 84.16M | 1.12B | 1.36B |
| Net Income | 829.77M | 878.44M | 591.63M | -628.79M | 510.09M | 715.41M |
Balance Sheet | ||||||
| Total Assets | 10.67B | 11.32B | 11.47B | 10.95B | 11.52B | 8.91B |
| Cash, Cash Equivalents and Short-Term Investments | 2.02B | 5.75B | 4.92B | 4.36B | 3.61B | 3.62B |
| Total Debt | 400.00M | 857.45M | 1.19B | 1.48B | 1.57B | 172.15M |
| Total Liabilities | 8.24B | 8.52B | 9.08B | 9.14B | 8.83B | 5.96B |
| Stockholders Equity | 2.43B | 2.80B | 2.39B | 1.81B | 2.69B | 2.93B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.37B | 901.23M | 1.38B | -708.88M | 338.84M |
| Operating Cash Flow | 0 | 1.46B | 1.21B | 1.78B | -213.40M | 669.08M |
| Investing Cash Flow | 0 | 236.62M | -292.00M | -325.63M | -510.15M | -278.35M |
| Financing Cash Flow | 0 | -859.23M | -361.39M | -702.63M | 712.28M | -392.52M |
GMO Pepabo, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3633, the sentiment is Positive. The current price of 2406.00 is below the 20-day moving average (MA) of 2434.30, below the 50-day MA of 2534.78, and above the 200-day MA of 2044.44, indicating a neutral trend. The MACD of -70.67 indicates Positive momentum. The RSI at 48.84 is Neutral, neither overbought nor oversold. The STOCH value of 65.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3633.
GMO Pepabo, Inc. Peers Comparison
Overall Rating
JP:443183Outperform- JP:363373Outperform
JP:443471Outperform
JP:376969Neutral
JP:377847Neutral
JP:366546Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4431 | 83Outperform | JPY 69.65B | 26.02 | ― | 0.67% | 20.70% | 56.44% |
| JP:3633 | 73Outperform | JPY 12.31B | 7.77 | ― | 2.88% | -3.72% | 138.33% |
| JP:4434 | 71Outperform | JPY 24.25B | 19.86 | ― | 1.31% | 23.79% | ― |
| JP:3769 | 69Neutral | JPY 657.63B | 25.74 | 21.67% | 1.98% | 13.19% | 25.73% |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| JP:3778 | 47Neutral | JPY 121.74B | 45.26 | ― | 0.16% | 25.84% | 71.45% |
| JP:3665 | 46Neutral | JPY 17.07B | 70.38 | ― | 7.32% | -1.71% | -7.98% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3633 | GMO Pepabo, Inc. | 2406.00 | 306.04 | 14.57% | |
| JP:3769 | GMO Payment Gateway | 8600.00 | 239.87 | 2.87% | |
| JP:3665 | ENIGMO, Inc. | 410.00 | 21.30 | 5.48% | |
| JP:3778 | SAKURA Internet Inc. | 3160.00 | -18.93 | -0.60% | |
| JP:4431 | Smaregi, Inc. | 3590.00 | 746.50 | 26.25% | |
| JP:4434 | Serverworks Co., Ltd. | 3060.00 | 1305.01 | 74.36% |
GMO Pepabo, Inc. Corporate Events
GMO Pepabo Lifts 2026 Profit Outlook and Dividend on Tax Benefit From Subsidiary Liquidation
GMO Pepabo, Inc. announced it will recognize an income tax benefit in the fiscal year ending December 31, 2026, stemming from deferred tax assets related to the special liquidation of consolidated subsidiary CN Co., Ltd. This tax effect significantly...
GMO Pepabo Lifts Profit Outlook Despite Lower First-Half Sales
GMO Pepabo reported consolidated net sales of ¥5.26 billion for the six months ended June 30, 2026, down 5.0% year on year, with operating profit falling 14.1% to ¥513 million but profit attributable to owners of parent surging 169.5% to ¥1.07 billio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 18, 2026